Position in ELDN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,004
+$2,041 QoQ
Shares Held
1,300
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Addison Advisors LLC holds $20,811 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
209 | $5,741 | |
| 2 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 3 | ADMA |
Adma Biologics, Inc.
|
500 | $4,185 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 6 | INCY |
Incyte Corp
|
6 | $680 | |
| 7 | CGEN |
Compugen Ltd
|
267 | $571 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
5 | $272 |
All Filings in ELDN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,004 | 1,300 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,963 | 1,300 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,367 | 1,300 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,523 | 1,300 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,407 | 1,300 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,356 | 1,300 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||